The other surprise that could come is an Omni-Car deal.
The likes of Johnson & Johnson have spent billions and years developing their CAR-T drug. So it's well worth them swinging $500m for a deal to use Omni-Car, to make their drug more effective, safer, controllable etc.
And then the floodgates open to other CAR-T pharmas who want to improve their drugs.
updated chart, page-7
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.006(10.3%) |
Mkt cap ! $41.87M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.2¢ | $59.73K | 1.126M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 128310 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 159704 | 1 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
-0.006 ( 7.96 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.2¢ | 665620 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| PTX (ASX) Chart |